Dynamic Contrast-Enhanced Ultrasound Parametric Maps to Evaluate Intratumoral Vascularization
暂无分享,去创建一个
Fabian Kiessling | Ingrid Leguerney | Nathalie Lassau | Jacques Bosq | F. Kiessling | J. Bosq | N. Lassau | P. Peronneau | J. Coulot | S. Pitre-Champagnat | I. Leguerney | L. Calmels | Pierre Peronneau | Stephanie Pitre-Champagnat | Lucie Calmels | Jeremy Coulot
[1] B. Goldberg,et al. Comparing contrast-enhanced color flow imaging and pathological measures of breast lesion vascularity. , 2008, Ultrasound in medicine & biology.
[2] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[3] F. Han,et al. Contrast-enhanced ultrasonic parametric perfusion imaging in the evaluation of antiangiogenic tumor treatment. , 2012, European journal of radiology.
[4] J. Gore,et al. Correlation Between Estimates of Tumor Perfusion From Microbubble Contrast‐Enhanced Sonography and Dynamic Contrast‐Enhanced Magnetic Resonance Imaging , 2006, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[5] P. Dayton,et al. Ultrasound assessment of angiogenesis in a matrigel model in rats. , 2006, Ultrasound in medicine & biology.
[6] Linda Chami,et al. Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. , 2011, Discovery medicine.
[7] James M Provenzale,et al. Imaging of angiogenesis: clinical techniques and novel imaging methods. , 2007, AJR. American journal of roentgenology.
[8] James H Thrall,et al. Imaging angiogenesis: applications and potential for drug development. , 2005, Journal of the National Cancer Institute.
[9] Andreas Makris,et al. Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment. , 2011, Journal of the National Cancer Institute. Monographs.
[10] N. Weidner. Chapter 14. Measuring intratumoral microvessel density. , 2008, Methods in enzymology.
[11] Nathalie Lassau,et al. Standardization of Dynamic Contrast-Enhanced Ultrasound for the Evaluation of Antiangiogenic Therapies: The French Multicenter Support for Innovative and Expensive Techniques Study , 2012, Investigative radiology.
[12] M. P. Hayball,et al. Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography , 2012, European Radiology.
[13] W J Niessen,et al. Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response? , 2011, Physics in medicine and biology.
[14] Aurore Bleuzen,et al. Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy , 2012, Breast Cancer Research and Treatment.
[15] Wolfhard Semmler,et al. Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound. , 2010, European journal of radiology.
[16] Namkug Kim,et al. Evaluation of Tumor Angiogenesis with a Second-Generation US Contrast Medium in a Rat Breast Tumor Model , 2008, Korean journal of radiology.
[17] S. L. Bridal,et al. Noninvasive contrast-enhanced US quantitative assessment of tumor microcirculation in a murine model: effect of discontinuing anti-VEGF therapy. , 2010, Radiology.
[18] Andrew Needles,et al. Assessment and Monitoring Tumor Vascularity With Contrast-Enhanced Ultrasound Maximum Intensity Persistence Imaging , 2011, Investigative radiology.
[19] Nathalie Lassau,et al. Validation of Dynamic Contrast-Enhanced Ultrasound in Predicting Outcomes of Antiangiogenic Therapy for Solid Tumors , 2014, Investigative radiology.
[20] David Cosgrove,et al. Imaging of perfusion using ultrasound , 2010, European Journal of Nuclear Medicine and Molecular Imaging.
[21] Wolfhard Semmler,et al. Vessel fractions in tumor xenografts depicted by flow- or contrast-sensitive three-dimensional high-frequency Doppler ultrasound respond differently to antiangiogenic treatment. , 2008, Cancer research.
[22] Anwar R. Padhani,et al. Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy , 2010, Targeted Oncology.
[23] Brandon Whitcher,et al. DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6 , 2011, British Journal of Cancer.
[24] P. Vrignaud,et al. Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography , 2008, Investigative radiology.
[25] J. Gore,et al. Coregistration of Ultrasonography and Magnetic Resonance Imaging with a Preliminary Investigation of the Spatial Colocalization of Vascular Endothelial Growth Factor Receptor 2 Expression and Tumor Perfusion in a Murine Tumor Model , 2009, Molecular imaging.
[26] Nathalie Lassau,et al. Methodology for quantifying interactions between perfusion evaluated by DCE-US and hypoxia throughout tumor growth. , 2007, Ultrasound in medicine & biology.
[27] Oriol Casanovas,et al. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. , 2005, Cancer cell.
[28] V. Goh,et al. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. , 2011, Radiology.
[29] Fabian Kiessling,et al. Comparing Dynamic Parameters of Tumor Vascularization in Nude Mice Revealed by Magnetic Resonance Imaging and Contrast‐Enhanced Intermittent Power Doppler Sonography , 2003, Investigative radiology.
[30] D. Cosgrove,et al. Contrast Ultrasonography: Necessity of Linear Data Processing for the Quantification of Tumor Vascularization , 2010, Ultraschall in der Medizin.
[31] E. Rofstad,et al. Changes in intratumor heterogeneity in blood perfusion in intradermal human melanoma xenografts during tumor growth assessed by DCE-MRI. , 2005, Magnetic resonance imaging.
[32] S. Koscielny,et al. Metastatic Renal Cell Carcinoma Treated with Sunitinib: Early Evaluation of Treatment Response Using Dynamic Contrast-Enhanced Ultrasonography , 2010, Clinical Cancer Research.
[33] Sarah Parisot,et al. Estimation of intra-operator variability in perfusion parameter measurements using DCE-US. , 2011, World journal of radiology.
[34] Panagiotis Samaras,et al. Quantitative Perfusion Analysis of Malignant Liver Tumors: Dynamic Computed Tomography and Contrast-Enhanced Ultrasound , 2012, Investigative radiology.
[35] P. Opolon,et al. Evaluation of Contrast-Enhanced Color Doppler Ultrasound for the Quantification of Angiogenesis In Vivo , 2001, Investigative radiology.
[36] H. Augustin,et al. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. , 2000, Cancer research.
[37] Linda Chami,et al. Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results. , 2011, Radiology.
[38] S. Kaul,et al. Assessment of ischemia-induced microvascular remodeling using contrast-enhanced ultrasound vascular anatomic mapping. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[39] L Barozzi,et al. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): Update 2011 on non-hepatic applications , 2011, Ultraschall in der Medizin.
[40] N. Weidner. Measuring Intratumoral Microvessel Density , 1998 .
[41] Tristan Barrett,et al. MRI of tumor angiogenesis , 2007, Journal of magnetic resonance imaging : JMRI.
[42] A. Padhani,et al. Multiparametric imaging of tumor response to therapy. , 2010, Radiology.